These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8525341)

  • 1. [Hemolytic anemia, myocardial infarction and xenotransplantation: what do they have in common?].
    Schifferli JA
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2217-25. PubMed ID: 8525341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the alternative pathway of complement by pH.
    Fishelson Z; Horstmann RD; Müller-Eberhard HJ
    J Immunol; 1987 May; 138(10):3392-5. PubMed ID: 2952717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxysmal nocturnal hemoglobinuria: a complement-mediated hemolytic anemia.
    DeZern AE; Brodsky RA
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):479-94. PubMed ID: 26043387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylphosphatidylinositol (GPI)-anchored membrane proteins in clinical pathophysiology of paroxysmal nocturnal hemoglobinuria (PNH).
    Shichishima T
    Fukushima J Med Sci; 1995 Jun; 41(1):1-13. PubMed ID: 8606038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets.
    Dixon RH; Rosse WF
    J Clin Invest; 1977 Feb; 59(2):360-8. PubMed ID: 833281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human soluble complement receptor 1 by a pig endothelial cell line inhibits lysis by human serum.
    Manzi L; Montaño R; Abad MJ; Arsenak M; Romano E; Taylor P
    Xenotransplantation; 2006 Jan; 13(1):75-9. PubMed ID: 16497215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement in hemolytic anemia.
    Brodsky RA
    Hematology Am Soc Hematol Educ Program; 2015; 2015():385-91. PubMed ID: 26637747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of cholinergic factors on the state of immunogenesis in animals with paroxysmal nocturnal hemoglobinuria-like hemolytic anemia].
    Martynova VA; Savina LS; Mikhaĭlova EA
    Probl Gematol Pereliv Krovi; 1980 Jun; 25(6):47-50. PubMed ID: 7393880
    [No Abstract]   [Full Text] [Related]  

  • 9. Multimeric tyrosine sulfate acts as an endothelial cell protectant and prevents complement activation in xenotransplantation models.
    Laumonier T; Walpen AJ; Matozan KM; Korchagina EY; Bovin NV; Haeberli A; Mohacsi PJ; Rieben R
    Xenotransplantation; 2004 May; 11(3):262-8. PubMed ID: 15099206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paroxysmal nocturnal hemoglobinuria and complement-mediated erythrocyte damage.
    Parker CJ
    Curr Opin Hematol; 1994 Mar; 1(2):151-6. PubMed ID: 9371274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood.
    Banz Y; Cung T; Korchagina EY; Bovin NV; Haeberli A; Rieben R
    Xenotransplantation; 2005 Nov; 12(6):434-43. PubMed ID: 16202066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of complement deficiencies.
    Pettigrew HD; Teuber SS; Gershwin ME
    Ann N Y Acad Sci; 2009 Sep; 1173():108-23. PubMed ID: 19758139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
    Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
    Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative status of red blood cells, neutrophils, and platelets in paroxysmal nocturnal hemoglobinuria.
    Amer J; Zelig O; Fibach E
    Exp Hematol; 2008 Apr; 36(4):369-77. PubMed ID: 18261835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of intravascular hemolysis in paroxysmal nocturnal hemoglobinuria (PNH).
    Nakakuma H
    Am J Hematol; 1996 Sep; 53(1):22-9. PubMed ID: 8813092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Xenotransplantation: physiopathology of hyperacute and differentiated rejection, and therapeutic perspectives].
    Malassagne B; Calmus Y; Houssin D; Weill B
    Pathol Biol (Paris); 2000 May; 48(4):377-82. PubMed ID: 10868402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
    Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
    Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinia virus complement control protein inhibits hyperacute xenorejection in a guinea pig-to-rat heterotopic cervical cardiac xenograft model by blocking both xenoantibody binding and complement pathway activation.
    Anderson JB; Smith SA; van Wijk R; Chien S; Kotwal GJ
    Transpl Immunol; 2003; 11(2):129-35. PubMed ID: 12799195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxysmal nocturnal hemoglobinuria: molecular pathogenesis and molecular therapeutic approaches.
    Nishimura J; Smith CA; Phillips KL; Ware RE; Rosse WF
    Hematopathol Mol Hematol; 1998; 11(3-4):119-46. PubMed ID: 9844822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.